Abstract
Continued hemorrhage remains a major cause of mortality in massively transfused patients, many of whom develop coagulopathy. A review of transfusion practice for these patients at our hospital revealed that a significant proportion received suboptimal transfusion therapy. Survivors had higher platelets count than non-survivors.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Transfusion and Apheresis Science |
Vol/bind | 43 |
Udgave nummer | 3 |
Sider (fra-til) | 401-5 |
Antal sider | 5 |
ISSN | 1473-0502 |
DOI | |
Status | Udgivet - 1 dec. 2010 |